Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for common hair loss, but more trials are needed to decide which are best.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

A new compound effectively inhibits human 5α-reductase 1.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Estrogen therapy can reduce skin aging but has cancer risks.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Valproic acid increases hair count in men with hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Methods accurately measure tamsulosin hydrochloride and finasteride in combined dosages.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.